INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
Subscribe
INDUSTRIALISATION
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
SEARCH
SEARCH
advanced search
CONNECTIVITY
CONNECTIVITY
Thierry Decock
Nemera
CONNECTED DEVICES – MEDICATION DELIVERY JUST GOT PERSONAL
Thierry Decock and Hadrien Gremillet explore how the obstacles to the adoption of connectivity can be overcome and how connected devices can deliver truly patient-centric care that will clearly improve adherence rates, whilst demonstrating a clear cost benefit to the pharmaceutical partner.
INTERVIEW
Dr Mircea Despa
BD (Becton Dickinson & Company)
MIRCEA DESPA & DOUG McCLURE, BD
In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.
CONNECTIVITY
Dr Benjamin Jung
H&T Presspart
THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A NETWORK PERSPECTIVE
Benjamin Jung uses a network theory approach to look at the ongoing issue of adherence when it comes to the treatment of asthma and COPD, and the players involved in overcoming it.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY RESTORING TRUST IN PHARMA COMMUNICATIONS
Napoleon Monroe analyses connectivity coverage at recent drug delivery conferences and, more broadly, in various publications, to evaluate the current direction, and explore the scope for connectivity to effect changes benefiting multiple stakeholders across a range of treatment categories.
CONNECTIVITY
Matt Jones
DCA
DON’T DEVELOP A CONNECTED DRUG DELIVERY DEVICE WITHOUT READING THIS
Matt Jones summarises some of the key challenges and opportunities in the development of connected drug delivery devices, focusing in detail on deciding what a connected drug delivery device should do, designing for a coin cell, direct cellular connection and antenna design.
EXPERT VIEW
Mark Tunkel
USER-CENTRED DEVICE CONNECTIVITY
Mark Tunkel and Carolyn Rose discuss the benefits of taking a user-needs approach, and mapping the patient journey, in a connectivity strategy.
EXPERT VIEW
Tim Frearson
PUSHING THE BOUNDARIES OF INFUSION PUMP INTEROPERABILITY
Interoperability is not a new concept for infusion pumps. But in many cases hospitals have been slow to embrace the full potential of connectivity. When is this likely to change? What will hospitals need when it does? And where should infusion pump manufacturers focus innovation efforts in the meantime? Tim Frearson considers the options.
CONNECTIVITY
Neil Williams
Phillips Medisize
LOW-COST CONNECTIVITY MEETS PATIENT & PHARMA MEDICATION MANAGEMENT NEEDS
Neil Williams describes the potential connected drug delivery systems hold to address serious challenges in healthcare, including poor adherence, and also deliver substantial value, and outlines the company’s highly scalable enterprise platform, the Connected Health Platform.
CONNECTIVITY
Craig Baker
Noble
ADHERENCE TO SELF-INJECTION REGIMENS CAN BE ENHANCED BY CONNECTED DEVICES
Craig Baker looks at the factors contributing to non-adherence and explores how connected devices can help patients follow their self-injection regimens.
CONNECTIVITY
Tsachi Shaked
ADDING CONNECTIVITY TO DRUG DELIVERY DEVICES
Tsachi Shaked explores how – as the trend towards moving healthcare from the hospital to the home continues – connectivity in drug delivery devices may be changing from being the exception to the rule.
INJECTION
Bjarne Sørensen
Phillips Medisize
A RE-USABLE CONNECTED AUTOINJECTOR CUSTOMISED FOR THE COMPANION
®
SAFETY SYRINGE SYSTEM
Bjarne Sørensen and John A. Merhige explore the latest developments in modular autoinjector platforms and the benefits for end users and pharmaceutical customers. They also discuss the two companies’ recent partnership for the development of a combined system that capitalises on important synergies between two compatible technologies.
PREFILLED SYRINGES
Justin Schroeder
PCI Pharma Services
BIOLOGIC MEDICINES AND PATIENT-CENTRICITY – A NEW PHASE OF HOPE
Justin Schroeder discusses how the increasing biologics and biosimilars market has driven innovation and a trend towards self-administration and user-centricity in the injectable drug delivery device market.
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY USING CONSUMER TECHNOLOGY TO CREATE REAL VALUE FOR PATIENTS
Napoleon Monroe presents the case for the C-Container, a collective term for a theoretical class of consumer product designed to work with various drug delivery combination products.
CONFERENCE REVIEW
James Arnold
2018 UNIVERSE OF PRE-FILLED SYRINGES AND INJECTION DEVICES
In October 2018, the Universe of Pre-Filled Syringes and Injection Devices conference, organised by the Parenteral Drug Association (PDA), was held in Orlando, FL, US.
EXPERT VIEW
Dr Philip Lance
THE EYES HAVE IT – EYE TRACKING EVOLUTION IN MEDICAL DEVICE DEVELOPMENT
Philip Lance and Phil Seeney discuss the recent surge in the use of eye-tracking technology in the field of human factors, providing an overview of the technique’s history and how it may be applied to medical devices in the future.
CONNECTIVITY
Eric Dessertenne
Biocorp
SUCCESSFUL CONNECTED DEVICE DEVELOPMENT REQUIRES A ROBUST VALUE PROPOSITION
Eric Dessertenn discusses the current status of connectivity in healthcare, its future, benefits both in terms of addressing adherence and big data analysis, and emphasises the need for a robust business case.
CONNECTIVITY
Dr Rajoshi Biswas
CAPMEDIC™: SIMPLIFYING INHALERS FOR REGULAR AND CORRECT USE
Rajoshi Biswa discusses the CapMedic device, which transforms a typical metered dose inhaler into a more user-friendly, efficacious delivery system.
CONNECTIVITY
Barbara Taylor
Portal Instruments
DARE TO BE DIFFERENT: INNOVATION VERSUS THE STATUS QUO
Barb Taylor discusses the need to differentiate drug products in an ever more competitive market by providing a delivery device that fits comfortably into a patient’s everyday lifestyle, and how Portal Instruments’ Prime needle-free injector does exactly that.
CONNECTIVITY
Dr Andreas Alt
Sensirion
FLOW MEASUREMENT IN SMART INHALERS FOR CONNECTED DRUG DELIVERY
Andreas Alt discusses the value of adding sensor technology to inhalers by means of an add-on device, both to help patients track and manage their disease, and to improve compliance by providing feedback on inhalation technique.
EXPERT VIEW
Tom Lawrie-Fussey
WE’RE OFF TO SEE THE WIZARD: “USE-LIKE” PROTOTYPING OF DIGITAL CONCEPTS
Tom Lawrie-Fussey and Lucy Sheldon introduce “Wizard of Oz” testing, named after the classic novel and film, whereby experimenters can field test concepts at a very early stage by giving the illusion of a finished product, saving potential costly and time-consuming changes further along the development process.
CONNECTIVITY
INNOVATIVE SOLUTIONS: DIGITAL DEVICES, DRUG DELIVERY AND SERVICES IN HEALTHCARE
The Medical Devices & Services team of Merck Group discuss the value of capturing “life data” using a connected device for improving patient adherence and therapeutic outcomes.
CONNECTIVITY
Neil Williams
Phillips Medisize
CONNECTIVITY OPENS THE DOOR TO INNOVATION AND OPPORTUNITY
Neil Williams outlines the need for connectivity in the future of healthcare and details Phillips-Medisize’s third-generation Connected Health Platform technology.
INTERVIEW
Dr Norbert Haberland
Datwlyer
NORBERT HABERLAND, DATWYLER
Norbert Haberland discusses Datwyler’s interests in the field of wearable technology in the healthcare sector.
EXPERT VIEW
Dr John N Pritchard
NEBULISERS: TIME TO REINVENT THE WHEEL
John Pritchard discusses the history of the nebuliser, its fall in popularity with the advent of DPIs and pMDIs, and its current resurgence due to the success of the mesh nebuliser, continuing on to how changing the development paradigm to utilise nebuliser technology more effectively can have significant benefits.
Prev
1
…
6
7
8
9
10
…
14
Next
Top
